₹1535.9
3.8 (0.25%) - 24 May 2025 03:26 PMConcord Biotech Limited is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology, supplying too many countries including regulated markets, such as the United States, Europe and Japan and India. It commanded a market share of over 20% by volume in 2022 across identified fermentation-based API products, including mupirocin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine. In 2016, it launched its formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States.
Industry - Pharmaceuticals & Drugs
* Please refer to the Standalone data if Consolidated financial data for the company is not available.
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED
| All logos and Trademarks registered with their respective owners.
